Darapladib China PK
Clinical trial NCT02000804 · COMPLETED
Trial details
- NCT number
- NCT02000804
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-23
- Primary completion
- 2014-01-04
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.